🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 4 study to evaluate the the efficacy of second generation a...
Status
Completed
Location
Asan medical center
Start Date
2021-10-01
Trial ID
NCT04877678
Treatments Being Tested
This is a clinical study to evaluate the safety and efficacy of a bepotasti...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2011-12
Trial ID
NCT01578278
Efficacy and safety study of bepotastine besilate ophthalmic solution in al...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2007-10
Trial ID
NCT00586664
A randomized, open-label, single-dose, 3-period, 6-sequence, 3-way crossove...
Status
Unknown
Location
Inha University Hospital
Start Date
2019-11-08
Trial ID
NCT04097951
Treatments Being Tested
The purpose of this study is to evaluate the drug-drug interaction between ...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02332044
Treatments Being Tested
The purpose of this study is to examine the safety and efficacy of bepotast...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2010-05
Trial ID
NCT01222299
Safety study for bepotastine besilate ophthalmic solution in normal volunte...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00586625
The purpose of this study is to evaluate the comfort of BEPREVE compared to...
Status
Completed
Location
Derek Cunningham
Start Date
2011-04
Trial ID
NCT01339507
The present study will be carried out to evaluate the antiallergic efficacy...
Status
Completed
Location
Hospital de Alta Complejidad El Cruce - Nestor Kirchner
Start Date
2021-03-10
Trial ID
NCT04776096
Treatments Being Tested
The purpose of this study is to compare the effect of Bepreve® with an arti...
Status
Completed
Location
Minnesota Eye Consultants, P.A.
Start Date
2011-05
Trial ID
NCT01346371
Treatments Being Tested